Ebola & Updates

Re: Ebola Update

It's here...
_http://www.cnn.com/2014/08/02/health/ebola-outbreak/index.html

With a few minutes notice, I'd rather sit in my lawn chair and watch a cometary bombardment than see possible slow ugly death knocking at the front door. 'Tis hard to watch this video and have a non-anticipatory attitude. :whistle: Methinks funny/strange to watch people in full bio-hazard apparel carry the Ebola infected while a few feet away is a couple dudes, one with a camera, wearing what looks like casual pants and short sleeve tee-shirts. Rrright... At first, two(2) bio-hazard garbed people carry what looks like a package/tray of some sort. Two(2) people using all four(4) hands carrying a tray of something very important, or dangerous, very very carefully. Sure seems that they didn't want to drop that puppy. Then out comes herr doctor, under his own power. Apparently weak but bipedal mobile. He walked through the "?back door?" on two(2) legs...
Yep, and people wonder why I smoke...
 
Re: Ebola Update

A few current articles circulating on Ebola.

What are US biowar researchers doing in the Ebola zone?
_http://jonrappoport.wordpress.com/2014/08/01/what-are-us-biowar-researchers-doing-in-the-ebola-zone/

Friday August 1, 2014 - This is a call for an immediate, thorough, and independent investigation of Tulane University researchers (see here and here) and their Fort Detrick associates in the US biowarfare research community, who have been operating in West Africa during the past several years.

What exactly have they been doing?

Exactly what diagnostic tests have they been performing on citizens of Sierra Leone?

Why do we have reports that the government of Sierra Leone has recently told Tulane researchers to stop this testing?

Have Tulane researchers and their associates attempted any experimental treatments (e.g., injecting monoclonal antibodies) using citizens of the region? If so, what adverse events have occurred?

The research program, occurring in Sierra Leone, the Republic of Guinea, and Liberia—said to be the epicenter of the 2014 Ebola outbreak—has the announced purpose, among others, of detecting the future use of fever-viruses as bioweapons.

Is this purely defensive research? Or as we have seen in the past, is this research being covertly used to develop offensive bioweapons?

For the last several years, researchers from Tulane University have been active in the African areas where Ebola is said to have broken out in 2014.

These researchers are working with other institutions, one of which is USAMRIID, the US Army Medical Research Institute of Infectious Diseases, a well-known center for biowar research, located at Fort Detrick, Maryland.

In Sierra Leone, the Tulane group has been researching new diagnostic tests for hemorrhagic fevers


Note: Lassa Fever, Ebola, and other labels are applied to a spectrum of illness that result in hemorrhaging.

Tulane researchers have also been investigating the use of monoclonal antibodies as a treatment for these fevers—but not on-site in Africa, according to Tulane press releases.

Here are excerpts from supporting documents.

Tulane University, Oct. 12, 2012, “Dean’s Update: Update on Lassa Fever Research” (.pdf here):

“In 2009, researchers received a five-year $7,073,538 grant from the National Institute of Health to fund the continued development of detection kits for Lassa viral hemorrhagic fever.

“Since that time, much has been done to study the disease. Dr. Robert Garry, Professor of Microbiology and Immunology, and Dr. James Robinson, Professor of Pediatrics, have been involved in the research of Lassa fever. Together the two have recently been able to create what are called human monoclonal antibodies. After isolating the B-cells from patients that have survived the disease, they have utilized molecular cloning methods to isolate the antibodies and reproduce them in the laboratory. These antibodies have been tested on guinea pigs at The University of Texas Medical Branch in Galveston and shown to help prevent them from dying of Lassa fever…

“Most recently, a new Lassa fever ward is being constructed in Sierra Leone at the Kenema Government Hospital. When finished, it will be better equipped to assist patients affected by the disease and will hopefully help to end the spread of it.” [The Kenema Hospital is one of the centers of the Ebola outbreak.]

Here is another release from Tulane University, this one dated Oct. 18, 2007. “New Test Moves Forward to Detect Bioterrorism Threats.”

“The initial round of clinical testing has been completed for the first diagnostic test kits that will aid in bioterrorism defense against a deadly viral disease. Tulane University researchers are collaborating in the project.

“Robert Garry, professor of microbiology and immunology at Tulane University, is principal investigator in a federally funded study to develop new tests for viral hemorrhagic fevers.

“Corgenix Medical Corp., a worldwide developer and marketer of diagnostic test kits, announced that the first test kits for detection of hemorrhagic fever have competed initial clinical testing in West Africa.

“The kits, developed under a $3.8 million grant awarded by the National Institutes of Health, involve work by Corgenix in collaboration with Tulane University, the U.S. Army Medical Research Institute of Infectious Diseases, BioFactura Inc. and Autoimmune Technologies.

“Clinical reports from the studies in Sierra Leone continue to show amazing results,” says Robert Garry, professor of microbiology and immunology at the Tulane University School of Medicine and principal investigator of the grant.

“We believe this remarkable collaboration will result in detection products that will truly have a meaningful impact on the healthcare in West Africa, but will also fill a badly needed gap in the bioterrorism defense.

“…The clinical studies are being conducted at the Mano River Union Lassa Fever Network in Sierra Leone. Tulane, under contract with the World Health Organization, implements the program in the Mano River Union countries (Sierra Leone, Liberia and Guinea) to develop national and regional prevention and control strategies for Lassa fever and other important regional diseases.

“Clinical testing on the new recombinant technology demonstrates that our collaboration is working,” says Douglass Simpson, president of Corgenix. “We have combined the skills of different parties, resulting in development of some remarkable test kits in a surprisingly short period of time. As a group we intend to expand this program to address other important infectious agents with both clinical health issues and threat of bioterrorism such as ebola.”

The third document is found on the Sierra Leone Ministry of Health and Sanitation Facebook page (no login required), dated July 23 at 1:35pm. It lays out emergency measures to be taken. We find this curious statement:“Tulane University to stop Ebola testing during the current Ebola outbreak.”

Why? Are the tests issuing false results? Are they frightening the population? Have Tulane researchers done something to endanger public health?

In addition to an investigation of these matters, another probe needs to be launched into all vaccine campaigns in the Ebola Zone. For example. HPV vaccine programs have been ongoing. Vials of vaccine must be tested to discover ALL ingredients. Additionally, it’s well known that giving vaccines to people whose immune systems are already severely compromised is dangerous and deadly.


On the Trail of an Ebola Cure
_http://www.israel21c.org/headlines/on-the-trail-of-an-ebola-cure/?utm_source=rss&utm_medium=rss&utm_campaign=on-the-trail-of-an-ebola-cure

Friday August 1, 2014 - As the most severe Ebola epidemic on record spreads through central Africa, infecting and killing hundreds of citizens and foreign aid workers, and raising the specter of outbreaks all over the world, an Israeli research team is working with survivors to develop antibodies against the lethal virus.

Dr. Leslie Lobel tells ISRAEL21c that he and fellow principal investigator Dr. Victoria Yavelsky have spent many years studying native immunity to Ebola and another equally lethal Equatorial African virus, Marburg, at Ben-Gurion University of the Negev’s Center for Emerging Diseases, Tropical Diseases and AIDS.

Ebola, a hemorrhagic fever, is one of the deadliest viruses in the world. It kills up to 90 percent of its victims, while Marburg, another hemorrhagic fever, kills up to 88%.
Ebola can be spread through sweat and saliva and there is no vaccine or cure. In the latest outbreak, the worst ever, more than 670 people have died, including Americans/

“Currently we’ve tracked all Ebola and Marburg virus survivors in Uganda, studied their immune responses to these viruses and identified survivors with a strong immune response,” he says. “We take blood samples from them and isolate monoclonal antibodies that neutralize the virus in our lab here at Ben-Gurion.”

Yavelsky and Lobel’s therapeutic approach was proven as a successful potential treatment by their colleagues in the US military, and at several other laboratories. This approach is regarded as the most promising way to prevent Ebola and Marburg, and it could be available within five years.

Lobel travels to Africa about five times a year. “We have set up a base laboratory in Entebbe, with our Ugandan colleagues, so that we can process human blood samples in under 12 hours from the time of collection, which is required for our work. After the samples are tested and deemed to be non-infectious, we ship them to Israel and our team here develops antibodies from the samples,” Lobel says.


With funding from the US National Institutes of Health and other resources, Lobel’s lab is now getting ready to test its human monoclonal antibodies in mice and non-human primates. This will be performed abroad because no live virus research is permitted in Israel.

Five-year plan

“We have a five-year plan and I believe we could have proof of concept with human monoclonal antibodies in monkeys in three to five years,” Lobel predicts. “If we can prove it in two animal models we can eventually use it in humans.”

He notes that the work being done at Ben-Gurion University is essential, since there are few studies on survivors of Ebola and there is no effective treatment thus far.

“We’re quite advanced in terms of studying the immune response in survivors in central Africa to develop a prophylactic and therapeutic [approach],” he tells ISRAEL21c.

The Israeli company Vecoy Nanomedicines is developing a biomedical technology platform that tricks a virus into “committing suicide,” a tactic that could neutralize viral threats like Ebola, hepatitis and HIV. However, Vecoy’s Dr. Eitan Eliram tells ISRAEL21c that Vecoy has not yet found sufficient funding to go forward.

Several other experimental vaccines and therapeutic approaches to Ebola and Marburg – mostly in the United States and Canada – are in various stages of development.

The current outbreak was noticed last February in Guinea, a country that is normally outside the usual ecosystem for Ebola, according to Lobel. At the end of March, the US Centers for Disease Control sent a team to assist Guinea Ministry of Health and World Health Organization (WHO) in formulating an international response to the outbreak that is now affecting other African countries including Sierra Leone, Liberia and Nigeria.


Poor compliance with health authorities and many customary practices are thought responsible for the rapid spread of the virus. Because of international travel, however, the Ebola specter hangs over much of the world. Accordingly, WHO has been holding emergency coordination meetings in several countries, and nations such as Liberia are sealing their borders and establishing screening centers. The most affected areas are imposing quarantines.

As of the end of July, Nancy Writebol and Dr. Ken Brantly, two American aid workers stationed at a Liberian hospital, tested positive for the Ebola virus.


Source: Flight en route to Liberia to evacuate Americans infected with Ebola
_http://www.cnn.com/2014/07/31/health/ebola-outbreak/index.html

Friday August 1, 2014 - CNN The fear began just after news broke Thursday that a long-range business jet with an isolation pod left the United States for Liberia, where it will evacuate two Americans infected with Ebola.

Twitter exploded with questions about the deadly virus, which according to the World Health Organization is believed to have killed hundreds in four West African nations. And with reaction to news that two infected Americans would soon be on their way back to the United States.

“Why are they doing this?” Robin Hunter asked in a post on Twitter.

While U.S. officials have remained mum on the issue, a source told CNN that a medical charter flight left from Cartersville, Georgia, on Thursday evening.

A CNN crew saw the plane depart shortly after 5 p.m. ET. The plane matched the description provided by the source, who spoke on condition of anonymity.

It was not immediately known when the two Americans — identified by the source as Dr. Kent Brantly and Nancy Writebol — would arrive in the United States, or where the plane would land.

At least one of the two will be taken to a hospital at Emory University, near the headquarters of the U.S. Centers for Disease Control and Prevention in Atlanta, hospital officials told CNN’s Dr. Sanjay Gupta.

The patient will be cared for in an isolation unit at the hospital that is separate from patient areas, Gupta said.

With the return of Brantly and Writebol to the United States, it will be the first time that patients diagnosed with Ebola will be known to be in the country.

Brantly and Writebol are described as being in stable-but-grave conditions, with both reportedly taking a turn for the worse overnight, according to statements released Thursday by the faith-based charity Samaritan’s Purse.

No known cure

There is no known cure or vaccine for Ebola, which the World Health Organization says is believed to have infected 1,323 people in Guinea, Liberia, Sierra Leone and Nigeria between March and July 27.

Of those suspected cases, it is believed to have been fatal in at least 729 cases, according to the health organization.

In the United States, the National Institutes of Health announced it will begin testing an experimental Ebola vaccine in people as early as September.

The federal agency has been working on the vaccine over the last few years and says they’ve seen positive results when they tested it on primates.

The NIH announcement came the same day as the CDC issued a Level 3 alert for Guinea, Liberia, and Sierra Leone, warning against any nonessential travel to the region.

As of now, the outbreak has been confined to West Africa. But it could spread via travel, especially since people who have Ebola may not know it; symptoms usually manifest two to 21 days.

The symptoms include fever, headaches, weakness and vomiting, and at an advanced stage there is internal and external bleeding.

The Eboloa outbreak is believed to be the worst in history, and even in a best-case scenario, it could take three to six months to stem the epidemic in West Africa, Dr. Thomas Frieden, director of the CDC, told reporters on Thursday.

Writebol gets ‘experimental serum’

Both Brantly, a 33-year-old who last lived in Texas, and Writebol were caring for Ebola patients in Liberia.

An experimental serum was administered to Writebol this week. Only one dose of the serum was available, and Brantly asked that it be given to his colleague, said Franklin Graham, president of Samaritan’s Purse.

Samaritan’s Purse said it did not have any additional detail about the serum.

At the same time, Brantly received a unit of blood from a 14-year-old boy who survived Ebola, the statement said. Brantly had treated the teen, it said.

It was not immediately clear what doctors hoped the blood transfusion would do for Brantly.

While blood transfusions have been tried before, Frieden told reporters no one really knows why some people survive and some don’t.

There have been questions about the the health of Brantly’s wife and his children, who left for Texas prior to his diagnosis.

In a statement released Thursday, Amber Brantly said she and her children “are physically fine.”

“We had left Liberia prior to Kent’s exposure to the virus,” she said. “I am always anxiously awaiting any news from Liberia regarding Kent’s condition.”

Meanwhile, Writebol’s husband, David, who like his wife is with Samaritan’s Purse, is near her, said their son Jeremy, who spoke with CNN’s Chris Cuomo from the United States.

But she is isolated from him, and he has to wear head-to-toe protective clothing similar to a hazmat suit so that he does not contract a disease that starts out with similar symptoms as a strong flu but can end in internal bleeding and death.

“Mom continues in stable condition but it’s very serious, and she’s still fighting,” her son said. “She’s weak, but she’s working through it.”

Liberian Information Minister Lewis Brown said his country could ill afford to lose health care workers like Writebol and Brantly.

“We join the families in prayers that they can come through this and become … shining examples that, if care is taken, one can come out of this.”

Another physician in West Africa was not so fortunate; Dr. Sheik Humarr Khan fell ill early last week while overseeing Ebola treatment at a Sierra Leone hospital and died days later.

Samaritan’s Purse and the missionary group Serving in Mission have recalled all nonessential personnel from Liberia.

The Peace Corps announced Wednesday it is doing the same, removing its 340 volunteers from the three severely affected nations.


Some residents in affected villages have accused medical workers of bringing the disease into the country and have barricaded their towns or otherwise blocked access to Ebola victims.

Koroma said he will deploy police and military to accompany the aid workers.

They will search house to house for the infirm and enforce orders designed to curb the virus’ spread.

American dies in Nigeria

One American, 40-year-old Patrick Sawyer, died in a Nigerian hospital earlier this month — having come from Liberia. He was in a plane to Lagos, when he became violently ill. He was planning to go back home to Minnesota to celebrate his daughters’ birthdays, but the disease took his life before he could.

The Nigerian government said Thursday it has located 10 more people who had contact with Sawyer, the first American who died in the Ebola outbreak. Meanwhile, none of the 67 people under surveillance and the two people in quarantine have shown symptoms of the disease, Nigerian Minister of Information Labaran Maku said.

A naturalized American citizen who worked in Liberia, Sawyer flew to Nigeria intending to attend a conference.

After exhibiting symptoms upon arrival July 20, he was hospitalized and died on July 25.

Ebola to land on U.S. soil for first time: Infected Americans are controversially airlifted back for treatment
_http://www.dailymail.co.uk/news/article-2712477/Dr-Kent-Brantly-battling-Ebola-passes-potentially-life-saving-experimental-serum-American-colleague-it.html#ixzz399dv6dsi

Two Americans battling Ebola are being flown from Liberia to Atlanta in specially outfitted planes – bringing the incurable disease to U.S. shores for the first time, it has been reported.

Dr Kent Brantly and hygienist Nancy Writebol, both of whom are said to be in ‘grave condition’, will be brought back to the U.S. one by one, sources told ABC News.


Emory University in Atlanta has confirmed that they will be taking one of the patients ‘in the next several days’ after they arrive in the U.S. in the Gulfstream jet. It is not clear which of the two patients they will be housing or where the second patient will go.

Emory and the Centers for Disease Control and Prevention, which is also based in Atlanta, have built a special containment unit to house the patient, who is in need of an extremely high level of isolation.

Containment: Inside the jet, the patients will be quarantined in these isolation tents called aeromedical biological containment systems

CNN reported that the CDC jet took off on Thursday to collect the victims.

Inside the aircraft, the patients will remain in a tent-like structure called an aeromedical biological containment system, which allows officials to move highly contagious patients without fear of exposure to pathogens.

According to WXIA, Emory’s isolation unit is on the ground floor and has three beds with the highest standards in negative pressure air handling, HEPA filtration and exhaust.

‘When this unit was being built, we hoped we’d never have to use the space to treat a serious communicable disease,’ said Emory epidemiologist Bruce Ribner.

However that’s precisely what will soon happen. The modified Gulfstream III took off from Cartersville, Georgia Thursday afternoon for the first-of-its-kind mission to collect the Ebola patients.
 
Re: Ebola Update

_http://hosted.ap.org/dynamic/stories/U/US_MED_EBOLA_AMERICANS?CTIME=2014-08-02-12-55-47 said:
ATLANTA (AP) -- The first Ebola victim to be brought to the United States from Africa was safely escorted into a specialized isolation unit Saturday at one of the nation's best hospitals, where doctors said they are confident the deadly virus won't escape.

[...]

In 2005, it handled patients with SARS, which unlike Ebola can spread like the flu when an infected person coughs or sneezes.

[url=https://www.sott.net/article/282930]Ebola: What you're not being told[/url] said:
Though the method of transmission in the study was not officially determined, one of the scientists involved, Dr. Gary Kobinger, from the National Microbiology Laboratory at the Public Health Agency of Canada, told BBC News that he believed that the infection was spread through large droplets that were suspended in the air.

"What we suspect is happening is large droplets; they can stay in the air, but not long; they don't go far," he explained. "But they can be absorbed in the airway, and this is how the infection starts, and this is what we think, because we saw a lot of evidence in the lungs of the non-human primates that the virus got in that way."

Translation: Ebola IS an airborne virus.

[...]

NOTE: We have reported on the fact that Ebola can spread through the air in three separate articles since March of 2014, here, here and here, however the corporate media has continued to misrepresent the vectors of transmission.

This particular strain of Ebola is not Ebola Zaire. This is a new strain, and it may in fact be more dangerous than the Zaire variety. Not because of any difference in the symptoms (the symptoms are identical), but because this new virus seems to be harder to contain. Whether this is due to some characteristic of the virus itself or merely dumb luck is uncertain at this time, but the rate at which this outbreak has extended its range is unprecedented.

Right now the question on everyone's minds is whether this virus will spread outside of Africa. Considering the fact that Ebola has a three week incubation period, can travel through the air, and has already hitchhiked onto an international flight, this is a very real possibility. There are some that are downplaying the probability of this outcome, and to be honest, I hope that they are right, but the simple fact of the matter is that these people are basing their assessment on the faulty premise that Ebola is not an airborne virus.
 
Re: Ebola Update

Al Today said:
It's here...
_http://www.cnn.com/2014/08/02/health/ebola-outbreak/index.html

With a few minutes notice, I'd rather sit in my lawn chair and watch a cometary bombardment than see possible slow ugly death knocking at the front door. 'Tis hard to watch this video and have a non-anticipatory attitude. :whistle: Methinks funny/strange to watch people in full bio-hazard apparel carry the Ebola infected while a few feet away is a couple dudes, one with a camera, wearing what looks like casual pants and short sleeve tee-shirts. Rrright... At first, two(2) bio-hazard garbed people carry what looks like a package/tray of some sort. Two(2) people using all four(4) hands carrying a tray of something very important, or dangerous, very very carefully. Sure seems that they didn't want to drop that puppy. Then out comes herr doctor, under his own power. Apparently weak but bipedal mobile. He walked through the "?back door?" on two(2) legs...
Yep, and people wonder why I smoke...

American aid worker stricken with Ebola arrives in U.S. for treatment
_http://news.yahoo.com/plane-carrying-u-aid-worker-ebola-leaves-liberia-140143113.html?clear=cache

Saturday August 2, 2014 - ATLANTA (Reuters) – An American aid worker infected with the deadly Ebola virus while in Liberia arrived in the United States from West Africa on Saturday and walked into an Atlanta hospital, wearing a bio-hazard suit, for treatment in a special isolation unit.

A chartered medical aircraft carrying Dr. Kent Brantly touched down at Dobbins Air Reserve Base in Marietta, Georgia, shortly before noon. Brantly was driven by ambulance, with police escort, to Emory University Hospital in Atlanta for treatment in a specially equipped room.

Television news footage showed three people in white biohazard suits step gingerly out of the ambulance. Two of them walked into the hospital, one seeming to lean on the other for support. A hospital spokesman confirmed that Brantly walked into the building under his own power.

Dr. Jay Varkey, an infectious disease specialist at Emory, said he could not comment on a treatment plan until Brantly had been evaluated. Since there is no known cure, standard procedures are to provide hydration with solutions containing electrolytes or intravenous fluids, according to the World Health Organization.

Brantly works for the North Carolina-based Christian organization Samaritan’s Purse. A second infected member of the group, missionary Nancy Writebol, will be brought to the United States on a later flight, as the medical aircraft is equipped to carry only one patient at a time.

SPECIALLY DESIGNED HOSPITAL ROOM

Brantly and Writebol were helping respond to the worst West African Ebola outbreak on record when they contracted the disease. Since February, more than 700 people in the region have died from the infection.

Despite concern among some in the United States over bringing Ebola patients to the country, health officials have said there is no risk to the public.

The facility at Emory, set up with the U.S. Centers for Disease Control and Prevention, is one of only four in the country with the facilities to deal with such cases.

“We have a specially designed unit, which is highly contained. We have highly trained personnel who know how to safely enter the room of a patient who requires this form of isolation,” Bruce Ribner, an infectious disease specialist at Emory, said Friday.

The plane used to bring Brantly to the United States was equipped with a plastic isolation tent, a medical bed, intravenous lines and monitoring equipment, according to the CDC, which called the set-up an Aeromedical Biological Containment System.

Brantly is a 33-year-old father of two young children. Writebol is a 59-year-old mother of two.

CDC spokeswoman Barbara Reynolds said this week that the agency was not aware of any Ebola patient ever being treated in the United States previously. But five people in the past decade have entered the country with either Lassa Fever or Marburg Fever, hemorrhagic fevers that are similar to Ebola.

The two Americans will be treated primarily by a team of four infectious disease physicians. The patients will be able to see loved ones through a plate-glass window and speak to them by phone or intercom.

“There is a little bit of worry,” Jenny Kendrix, 46, said of having Brantly brought to the same hospital where her husband is being treated for cancer.



Outbreak of Ebola in Guinea, Liberia, and Sierra Leone
_http://www.cdc.gov/vhf/ebola/outbreaks/guinea/

Thursday July 31, 2014

Highlights

July 27, 2014, the Guinea Ministry of Health announced a total of 460 suspect and confirmed cases of Ebola virus disease (EVD), including 339 fatal cases.

Affected districts include Conakry, Guéckédou, Macenta, Kissidougou, Dabola, Djingaraye, Télimélé, Boffa, Kouroussa, Dubreka, Fria, Siguiri; several are no longer active areas of EVD transmission (see map).

336 cases across Guinea have been confirmed by laboratory testing to be positive for Ebola virus infection.

In Guinea’s capital city, Conakry, 89 suspect cases have been reported to meet the clinical definition for EVD, including 40 fatal cases.

July 27, 2014, the Ministry of Health and Sanitation of Sierra Leone and WHO reported a cumulative total of 533 suspect and confirmed cases, including 473 laboratory confirmations and 233 reported fatal cases.

Cases have been reported from 11 Sierra Leone districts.

July 27, 2014, the Ministry of Health and Social Welfare of Liberia and WHO have reported 329 suspect and confirmed EHF cases (including 100 laboratory confirmations) and 156 reported fatalities.

July 27, 2014, the Nigerian Ministry of Health and WHO reported one fatal probable case.

Genetic analysis of the virus indicates that it is closely related (97% identical) to variants of Ebola virus (species Zaire ebolavirus) identified earlier in the Democratic Republic of the Congo and Gabon (Baize et al. 2014External Web Site Icon).

The Guinean Ministry of Health, the Ministry of Health and Sanitation of Sierra Leone, the Ministry of Health and Social Welfare of Liberia, and the Nigerian Ministry of Health are working with national and international partners to investigate and respond to the outbreak.

Outbreak Update

The World Health Organization, in partnership with the Ministries of Health in Guinea, Sierra Leone, Liberia, and Nigeria announced a cumulative total of 1323 suspect and confirmed cases of Ebola virus disease (EVD) and 729 deaths, as of July 27, 2014. Of the 1323 clinical cases, 909 cases have been laboratory confirmed for Ebola virus infection.


Peace Corps leaves West Africa as Ebola outbreak expands
_http://rt.com/usa/176856-peace-corps-ebola-outbreak-africa/

Thursday July 31, 2014 -The US Peace Corps announced on Wednesday that it was removing its 340 volunteers from West Africa due to recent Ebola outbreak, while the federal government is being urged to fast-track a new a drug that could possibly stave off a global pandemic.

According to Reuters, 130 volunteers will leave Sierra Leone, while another 108 and 102 will depart Liberia and Guinea, respectively. The Peace Corps blamed the virus’ continued spread for the decision.

“The Peace Corps today announced that it is temporarily removing its volunteers from Liberia, Sierra Leone and Guinea due to the increasing spread of the Ebola virus,” the organization said in a statement to the news service.

Since February, 672 people have been killed in all three countries, making the recent outbreak the most devastating on record, per the World Health Organization.

Meanwhile, the US State Department confirmed one American citizen has died from the virus – which triggers diarrhea and vomiting before causing internal and external bleeding. Two other aid workers have been infected and are in serious condition.

As RT reported on Tuesday, Sierra Leone’s only specialist on Ebola has also died, not even one week after being diagnosed with the virus. The current fatality rate stands at 60 percent, which is lower than the 90 percent rate typically associated with the disease.

As the highly contagious virus continues to raise concern across the world, activists have started apetition on Change.org pushing the US Food and Drug Administration to speed up the authorization of new medication that could potentially stop the virus in its tracks. There’s currently no cure for Ebola, but several drugs and vaccines are currently being tested.

“One of the most promising is TKM-Ebola manufactured by Tekmira Pharmaceuticals,” the petition states. “This drug has been shown to be highly effective in killing the virus in primates and Phase 1 clinical trials to assess its safety in humans were started earlier this year.”

The petition points to the fact that there’s been one confirmed case of the disease being transferred via air travel – from Liberia to Nigeria – and suggests the impending shadow of a pandemic makes fast-tracking the drug’s approval necessary.

“In view of this it’s imperative that the development of these drugs be fast-tracked by the FDA and the first step should be releasing the hold on TKM-Ebola. There is a precedent for fast tracking anti-Ebola drugs in emergency cases as happened last year when a researcher was exposed to the virus and received an experimental vaccine.”

Speaking with the Daily Mail, Professor Jeremy Farrar of the Welcome Trust global charity said drugs that have already been tested on humans should be deployed to the areas where they could be the most beneficial.

“It’s ridiculous that we haven’t got these (experimental) products out of labs and animal trials and into human testing, and at least offered to people,” he said.

“If you had a 60 per cent chance of dying tomorrow, and there was something that had been tested in healthy volunteers (but not yet tried in patients or approved), would you take it?”


Ebola Virus – Pathogen Safety Data Sheet
_http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php

Wednesday July 30, 2014

Public Health Agency of Canada

SECTION I - INFECTIOUS AGENT

NAME: Ebola virus
 
Re: Ebola Update

Quoted article has had updates.

_http://scgnews.com/ebola-what-youre-not-being-told said:
Translation: Ebola IS an airborne virus.

UPDATE: Someone pointed out that in medical terms, if the virus is transferred through tiny droplets in the air this would technically not be called an "airborne virus". Airborne, in medical terms would mean that the virus has the ability to stay alive without a liquid carrier. On one hand this is a question of semantics, and the point is well taken, but keep in mind that the study did not officially determine how the virus traveled through the air, it merely established that it does travel through the air. Doctor Kobinger's hypothesis regarding droplets of liquid is just that, a hypothesis. For the average person however what needs to be understood is very simple: if you are in a room with someone infected with Ebola, you are not safe, even if you never touch them or their bodily fluids, and this is not what you are being told by the mainstream media. Essentially I am using the word "airborne" as a layman term (which kind of makes sense, since I am a layman in this field).

[...]

UPDATE: A number of people have requested that I comment on the fact that the Americans infected by Ebola are right now being flown into the U.S. My personal opinion is that this particular move will not lead to the virus getting out. This event is going to be highly scrutinized, and the isolation security should be at max. The real danger isn't in these highly controlled transfers and quarantines, but rather in the ongoing flow of air travel from these regions. Thirty five countries are merely one flight away from an Ebola zone right now.

Why is this random air travel more dangerous?

Because if it gets in when people aren't looking, it can spread before containment measures are put into place.
 
Re: Ebola Update

Hmmm mainstream media braying all over about Ebola :huh:

Ebola outbreak ‘moving faster than efforts to control it,’ says WHO chief

Sez WHO chief - well i don't buy anything from alphabet salad agencies especially beginning with W... :thdown:

"Ebola gone airborne" and despite this some infected people to be transported to Germany and Atlanta :huh: - WHO is crazy here?

Bio hazard drill in NY :huh:

It seems to me that someone is staging some panic scenario like in cases of bird/pig flues...
And suddenly Monsanto is mentioned like working (already) on remedy - just like they knew in advance:

Some TC (total conspiracy) angle on this:

*US bioweapons lab with links to the Bill and Melinda Gates Foundation at core of Ebola epidemic

*CDC admits hospitals and vaccines cause Ebola

*UK and US mainstream media fuel Ebola hysteria

*The Telegraph hypes Ebola as a threat to Britain

*Epidemic and pandemic plans allow for implementation of martial law

Is Gates in Monsanto?

At the epicentre of the current Ebola epidemic is the Kenema Government Hospital in Sierra Leone, which houses a US a biosecurity level 2 bioweapons research lab with links to the Bill and Melinda Gates Foundation and Soros Foundation.

snip

Connecting the dots, it is reasonable to ask for an investigation into whether this particular US bioweapons lab at the geographical epicentre of the current Ebola outbreak actually caused the Ebola outbreak.

In 2009, Baxter in Austria was caught contaminating 72 kilos of seasonal flu with the deadly bird flu virus in its biosecurity level 3 laboratory. It later emerged from documents posted on Wikileaks that Baxter was a US defense or military asset.

Facts and documents as well as current mainstream media hype point to plans for false flag Ebola bioterrorism attacks in hospitals and clinics against US and UK citizens using occasions like the Commonwealth Games in Scotland to spread panic.

The purpose is to implement martial law measures contained in epidemic and pandemic plans and so gain total control of the population at a time when the financial system is close to collapse.

From:_http://birdflu666.wordpress.com/2014/07/08/us-bioweapons-lab-in-sierra-leone-at-the-epicentre-of-ebola-outbreak/

Added: Maybe there is a plan to spread Ebola through "preventive vaccinations in hospitals across US and Europe? Just like it was done for bird/swine flu? Sickos
 
Re: Ebola Update

I find the arrival of Dr. Kent Brantly in the US, coinciding, more or less, with the decision to pull ground troops out of Gaza, quite curious.

Kris
 
Re: Ebola Update

anyone know anything about this? It's apparently a patent for Ebola made out to the US govt., or so the bloke who posted on youtube says. Here's the vid:

_https://www.youtube.com/watch?v=vyU7OJOHlcI

and here's the link to the patent provided by the youtube video:

_http://www.google.com/patents/CA2741523A1?cl=en

Is this legit? Does it actually mean that the US created Ebola? It's a bit too technical for me to break down and get the answers myself. Is Ebola a manufactured bioweapon and is this the proof?

Somehow I doubt that it would be this easy, but you never know 'less you ask.
 
Re: Ebola Update

Fester said:
Is this legit? Does it actually mean that the US created Ebola? It's a bit too technical for me to break down and get the answers myself. Is Ebola a manufactured bioweapon and is this the proof?

I was also wondering about this. If this new Ebola strain is a natural mutation, then what's at the horizon is the PTB attempting to use this outbreak to their advantage, like Monsanto funding new "medicines" and vaccines, and having a new "justification" for furthering draconian measures, as in the use of military force against the population, as well as forced vaccinations.
 
Re: Ebola Update

Fester said:
anyone know anything about this? It's apparently a patent for Ebola made out to the US govt., or so the bloke who posted on youtube says. Here's the vid:

_https://www.youtube.com/watch?v=vyU7OJOHlcI

and here's the link to the patent provided by the youtube video:

_http://www.google.com/patents/CA2741523A1?cl=en

Is this legit? Does it actually mean that the US created Ebola? It's a bit too technical for me to break down and get the answers myself. Is Ebola a manufactured bioweapon and is this the proof?

Somehow I doubt that it would be this easy, but you never know 'less you ask.

Hi Fester, in case you haven't done so, I would highly recommend reading Mike Baillie's New Light on the Black Death and Scott & Duncan's Return of the Black Death. In his book, Mike correlates tree rings data and ammonium concentrations in ice cores with natural catastrophes that appear to have been caused by cometary strikes and links it to the outbreak of the Black Death and other major pandemics throughout history. Scott & Duncan provide good evidence to show that the Black Death wasn't caused by bubonic plague as all the symptoms tend to support the fact that hemorrhagic fever was behind the pandemic. They then touch on the Ebola virus and show the Ebola-like nature of the hemorrhagic plague.

While we shouldn't completely discount the possibility of it being a human fabrication, I would be inclined to support the cometary nature of Ebola. If the current or future strains are able to survive in even a slightly colder environment, the virus would get out of control and kill literally millions. The PTB won't be spared either.

Aiming said:
I was also wondering about this. If this new Ebola strain is a natural mutation, then what's at the horizon is the PTB attempting to use this outbreak to their advantage, like Monsanto funding new "medicines" and vaccines, and having a new "justification" for furthering draconian measures, as in the use of military force against the population, as well as forced vaccinations.

Yes, I agree that Monstanto along with other big corporations will exploit the situation and come up with vaccines and other medicines that they would claim will prevent people or highly reduce the risk of being infected. However, I think that once the big one hits, their vaccines will be shown to be ineffective and it will come back to them pretty hard.
 
Re: Ebola Update

Eboard10 said:
While we shouldn't completely discount the possibility of it being a human fabrication, I would be inclined to support the cometary nature of Ebola. If the current or future strains are able to survive in even a slightly colder environment, the virus would get out of control and kill literally millions. The PTB won't be spared either.

I think so too, since some alternative media outlets are already going into that direction that it is fabricated is kind of delivering a picture that everything is under control, when most likely it is not. But lets see how it turns out. The only chance we have is prepping our diet.

Eboard10 said:
Aiming said:
I was also wondering about this. If this new Ebola strain is a natural mutation, then what's at the horizon is the PTB attempting to use this outbreak to their advantage, like Monsanto funding new "medicines" and vaccines, and having a new "justification" for furthering draconian measures, as in the use of military force against the population, as well as forced vaccinations.

Yes, I agree that Monstanto along with other big corporations will exploit the situation and come up with vaccines and other medicines that they would claim will prevent people or highly reduce the risk of being infected. However, I think that once the big one hits, their vaccines will be shown to be ineffective and it will come back to them pretty hard.

And even these vaccines could then further spread the disease, beside weakening the immune system. But about the government, they will most definitely try to tighten the control over the people and using Ebola to their advantage.
 
Re: Ebola Update

Eboard10 said:
[...]
While we shouldn't completely discount the possibility of it being a human fabrication, I would be inclined to support the cometary nature of Ebola.
[...]

Yep, perhaps Ebola indeed started this way, BUT... For psychopathic reasons beyond my comprehension I can "see" men/women seeking monetary reward with tinkering with that time bomb. We all know about how memories can become skewed but years ago I think remembering hearing and reading "stories" about people playing around with Ebola. One would think to find a cure? But with what I've seen, they may well have been working the means to turn Ebola into a weapon. Shoot... there's lots-o-money to be made with bigger better badder ways to kill each other. My imagination can see these diligent workers in some secret facility thinking themselves being secure and safe. And then... OOPSIE... The power goes off and containment is compromised and somebody saying "oh krap".
:headbash: :headbash: :headbash:
 
Re: Ebola Update

Gawan said:
Eboard10 said:
Yes, I agree that Monstanto along with other big corporations will exploit the situation and come up with vaccines and other medicines that they would claim will prevent people or highly reduce the risk of being infected. However, I think that once the big one hits, their vaccines will be shown to be ineffective and it will come back to them pretty hard.

And even these vaccines could then further spread the disease, beside weakening the immune system. But about the government, they will most definitely try to tighten the control over the people and using Ebola to their advantage.

Well, it looks like they aren't even trying to come up with a vaccine at the moment. Some good news for once.

http://www.sott.net/article/283121-Drugs-firms-not-trying-to-find-Ebola-vaccine-because-virus-is-only-killing-Africans
 
Re: Ebola Update

Just thought I'd throw in what I know about homeopathic remedies that have been recommended for Ebola.

Back in 1995 while learning about homeopathy I purchased a book called "Poisons That Heal". The various Ebola viruses were mentioned (Marburg, Reston, Sudan and Zaire). The main remedy recommended for the Ebola viruses was Crolatus Horridus ... or venom of the rattlesnake.

Several other remedies recommended for Ebola are in order Phosphorus (made from phosphorus and should be handled and used with care), Lachesis (surukuku snake) and Bothrops (yellow viper),

These remedies can be easily and inexpensively purchased. So to cover all bases besides diet, smoking and sleep, it might be prudent to have these remedies on-hand. FWIW.

~ EB
 
Back
Top Bottom